Detection of anthracycline-induced cardiotoxicity: is there light at the end of the tunnel?
暂无分享，去创建一个
[1] Shinobu Nakamura,et al. Brain Natriuretic Peptide Is a Predictor of Anthracycline-Induced Cardiotoxicity , 2001, Acta Haematologica.
[2] R H Hruban,et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. , 2000, The New England journal of medicine.
[3] J. Hartikainen,et al. Natriuretic peptides during the development of doxorubicin‐induced left ventricular diastolic dysfunction , 2002, Journal of internal medicine.
[4] P. Krishnaswamy,et al. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. , 2001, Journal of cardiac failure.
[5] P. Singal,et al. Doxorubicin-induced cardiomyopathy. , 1998, The New England journal of medicine.
[6] T. Fleming,et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. , 2001, The New England journal of medicine.
[7] G. Martinelli,et al. Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.